WO2009066681A1 - 乳酸菌含有製剤 - Google Patents

乳酸菌含有製剤 Download PDF

Info

Publication number
WO2009066681A1
WO2009066681A1 PCT/JP2008/070995 JP2008070995W WO2009066681A1 WO 2009066681 A1 WO2009066681 A1 WO 2009066681A1 JP 2008070995 W JP2008070995 W JP 2008070995W WO 2009066681 A1 WO2009066681 A1 WO 2009066681A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
acid bacterium
function
nite
strain
Prior art date
Application number
PCT/JP2008/070995
Other languages
English (en)
French (fr)
Inventor
Airo Tategaki
Toyoki Watanabe
Kazuya Hamada
Original Assignee
Kaneka Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corporation filed Critical Kaneka Corporation
Priority to JP2009542564A priority Critical patent/JP5554994B2/ja
Priority to EP08851191.0A priority patent/EP2223697B1/en
Priority to MX2010005453A priority patent/MX2010005453A/es
Priority to US12/743,485 priority patent/US20100278795A1/en
Publication of WO2009066681A1 publication Critical patent/WO2009066681A1/ja
Priority to US14/642,796 priority patent/US9737577B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus

Abstract

　　本発明の目的は、安全性が高い乳酸菌またはその該乳酸菌由来成分を含有する、有用な組成物を提供する事にある。本発明は、ラクトバチルス・デルブリッキー・サブスピーシーズ・ラクティス　ＫＲ－０３７株（ＮＩＴＥ　ＢＰ－３９５）、ラクトバチルス・デルブリッキー・サブスピーシーズ・ラクティス　ＫＬＡＢ－４株（ＮＩＴＥ　ＢＰ－３９４）、およびそれらの変異体からなる群より選択される少なくとも1つの乳酸菌またはその乳酸菌由来成分を含有する組成物に関する。本発明の組成物は、優れた抗アレルギー機能を有し、さらには、抗自己免疫疾患機能、糖尿病改善機能、中性脂肪低減機能など少なくとも１つは併せ持つ製剤として有用である。
PCT/JP2008/070995 2007-11-19 2008-11-19 乳酸菌含有製剤 WO2009066681A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2009542564A JP5554994B2 (ja) 2007-11-19 2008-11-19 乳酸菌含有製剤
EP08851191.0A EP2223697B1 (en) 2007-11-19 2008-11-19 Lactic acid bacterium-containing preparation
MX2010005453A MX2010005453A (es) 2007-11-19 2008-11-19 Preparacion que contiene bacteria de acido lactico.
US12/743,485 US20100278795A1 (en) 2007-11-19 2008-11-19 Lactic acid bacterium-containing preparation
US14/642,796 US9737577B2 (en) 2007-11-19 2015-03-10 Lactic acid bacterium-containing preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007299503 2007-11-19
JP2007-299503 2007-11-19

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/743,485 A-371-Of-International US20100278795A1 (en) 2007-11-19 2008-11-19 Lactic acid bacterium-containing preparation
US14/642,796 Division US9737577B2 (en) 2007-11-19 2015-03-10 Lactic acid bacterium-containing preparation

Publications (1)

Publication Number Publication Date
WO2009066681A1 true WO2009066681A1 (ja) 2009-05-28

Family

ID=40667503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070995 WO2009066681A1 (ja) 2007-11-19 2008-11-19 乳酸菌含有製剤

Country Status (5)

Country Link
US (2) US20100278795A1 (ja)
EP (1) EP2223697B1 (ja)
JP (1) JP5554994B2 (ja)
MX (1) MX2010005453A (ja)
WO (1) WO2009066681A1 (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012036158A (ja) * 2010-08-11 2012-02-23 Sapporo Breweries Ltd 中性脂肪低減剤
JP2012056921A (ja) * 2010-09-13 2012-03-22 Kaneka Corp 生菌製剤
JP2019206520A (ja) * 2018-05-28 2019-12-05 株式会社ライフ・クオリティ研究所 血糖値スパイク改善剤及び血糖値改善組成物
WO2021111981A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 認知症の予防又は改善用剤及びそれを含む組成物
JPWO2021111983A1 (ja) * 2019-12-02 2021-06-10
JPWO2021111982A1 (ja) * 2019-12-02 2021-06-10
WO2021111980A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 起立性低血圧の予防又は改善用剤及びそれを含む組成物
JP7426820B2 (ja) 2019-12-27 2024-02-02 雪印メグミルク株式会社 食後血糖値上昇抑制用組成物及びその製造方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6777911B2 (ja) * 2016-08-17 2020-10-28 株式会社明治 抗インフルエンザ薬による獲得免疫機能低下抑制用発酵乳およびその製造方法
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
KR102194286B1 (ko) * 2018-02-08 2020-12-22 주식회사 엠디헬스케어 락토코커스 속 세균 유래 나노소포 및 이의 용도
TWI776433B (zh) * 2021-03-22 2022-09-01 生合生物科技股份有限公司 戴白氏乳桿菌乳酸亞種ldl557分離株及其用途

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JPH107577A (ja) 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
JPH10298083A (ja) 1997-04-28 1998-11-10 Wakamoto Pharmaceut Co Ltd 高脂血症治療用組成物および高脂血症対応食品
JP3585487B1 (ja) 2003-03-13 2004-11-04 麒麟麦酒株式会社 抗アレルギー用組成物
WO2006073145A1 (ja) * 2005-01-04 2006-07-13 Calpis Co., Ltd 抗アレルギー効果を有する乳酸菌の製造法
JP2007070249A (ja) * 2005-09-05 2007-03-22 Shinshu Univ 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品
JP2007082403A (ja) * 2004-03-26 2007-04-05 Nippon Medicine:Kk ユッカ抽出物、キラヤ抽出物及び乳酸菌の複合組成物を含有する飲食品及びその製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
US20040047849A1 (en) * 2002-09-11 2004-03-11 Genmont Biotech Inc. Use of some lactobacillus strains in treating allergy

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JPH107577A (ja) 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
JPH10298083A (ja) 1997-04-28 1998-11-10 Wakamoto Pharmaceut Co Ltd 高脂血症治療用組成物および高脂血症対応食品
JP3585487B1 (ja) 2003-03-13 2004-11-04 麒麟麦酒株式会社 抗アレルギー用組成物
JP2007082403A (ja) * 2004-03-26 2007-04-05 Nippon Medicine:Kk ユッカ抽出物、キラヤ抽出物及び乳酸菌の複合組成物を含有する飲食品及びその製造法
WO2006073145A1 (ja) * 2005-01-04 2006-07-13 Calpis Co., Ltd 抗アレルギー効果を有する乳酸菌の製造法
JP2007070249A (ja) * 2005-09-05 2007-03-22 Shinshu Univ 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2223697A4

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012036158A (ja) * 2010-08-11 2012-02-23 Sapporo Breweries Ltd 中性脂肪低減剤
JP2012056921A (ja) * 2010-09-13 2012-03-22 Kaneka Corp 生菌製剤
JP2019206520A (ja) * 2018-05-28 2019-12-05 株式会社ライフ・クオリティ研究所 血糖値スパイク改善剤及び血糖値改善組成物
WO2021111981A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 認知症の予防又は改善用剤及びそれを含む組成物
JPWO2021111983A1 (ja) * 2019-12-02 2021-06-10
JPWO2021111982A1 (ja) * 2019-12-02 2021-06-10
WO2021111982A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 ストレス障害の予防又は改善用剤及びそれを含む組成物
JPWO2021111981A1 (ja) * 2019-12-02 2021-06-10
WO2021111980A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 起立性低血圧の予防又は改善用剤及びそれを含む組成物
WO2021111983A1 (ja) * 2019-12-02 2021-06-10 株式会社ライフ・クオリティ研究所 機能性身体症候群の予防又は改善用剤及びそれを含む組成物
JPWO2021111980A1 (ja) * 2019-12-02 2021-06-10
JP7057039B2 (ja) 2019-12-02 2022-04-19 株式会社ライフ・クオリティ研究所 認知症の予防又は改善用剤及びそれを含む組成物
JP7063514B2 (ja) 2019-12-02 2022-05-09 株式会社ライフ・クオリティ研究所 起立性低血圧の予防又は改善用剤及びそれを含む組成物
JP7072965B2 (ja) 2019-12-02 2022-05-23 株式会社ライフ・クオリティ研究所 ストレス障害の予防又は改善用剤及びそれを含む組成物
JP7072966B2 (ja) 2019-12-02 2022-05-23 株式会社ライフ・クオリティ研究所 機能性身体症候群の予防又は改善用剤及びそれを含む組成物
CN114786693A (zh) * 2019-12-02 2022-07-22 生活质量研究所 直立性低血压的预防或改善用剂和包含其的组合物
JP7426820B2 (ja) 2019-12-27 2024-02-02 雪印メグミルク株式会社 食後血糖値上昇抑制用組成物及びその製造方法

Also Published As

Publication number Publication date
US9737577B2 (en) 2017-08-22
EP2223697A4 (en) 2011-04-27
US20100278795A1 (en) 2010-11-04
JP5554994B2 (ja) 2014-07-23
US20150182566A1 (en) 2015-07-02
MX2010005453A (es) 2010-08-31
EP2223697B1 (en) 2016-04-06
JPWO2009066681A1 (ja) 2011-04-07
EP2223697A1 (en) 2010-09-01

Similar Documents

Publication Publication Date Title
WO2009066681A1 (ja) 乳酸菌含有製剤
WO2009112361A3 (en) Synbiotic mixture
NZ598751A (en) Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175))
WO2009130423A3 (fr) Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices
WO2009142472A3 (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
WO2008117267A3 (en) Probiotic bifidobacterium strains
WO2009043856A3 (en) Modulation of tissue fatty acid composition of a host by human gut bacteria
WO2008117266A3 (en) Probiotic bifidobacterium strains
EP1854363B8 (en) Fermented tea beverage and tea beverage
WO2006091103A3 (en) Nutritional composition with probiotics
WO2009122042A3 (fr) Souche de lactobacillus rhamnosus
IL178686A (en) Preparations of bacterial strain of lactic acid and their uses
PL2561880T3 (pl) Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
MX2010007011A (es) Composicion para alimentacion humana y/o animal, sus usos, y levaduras.
WO2009065905A3 (en) Composition with synbiotics
WO2007144770A3 (en) Bacterium
WO2011106322A3 (en) Biomarkers for acute ischemic stroke
EP2452891A3 (en) Complementary personal lubricant compositions and delivery system
BR112013028705A2 (pt) cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes
WO2009013709A3 (en) Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
TW200700074A (en) Inducer of t cell apoptosis
WO2010096550A3 (en) Lactobacillus supplement for alleviating type 1 diabetes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08851191

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009542564

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2010/005453

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008851191

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12743485

Country of ref document: US